Global Acute Kidney Injury Treatment Market Estimated to Value Over USD 1.8 Billion by 2026 End

  • 23 Sep 2019

The Global Acute Kidney Injury Treatment Market is expected to value over USD 1.8 billion by 2026 end and register a CAGR of over 6.4% during the forecast period 2019-2026.

 

The factors bolstering the acute kidney injury treatment market growth are the rise in geriatric population and increasing cases of acute kidney injuries. Furthermore, the rise in research and development activities are identified as acute kidney injury treatment market trends. Initiatives launched by governments in healthcare industry aiming towards technological advancements are expected to increase acute kidney injury treatment market size. 

 

The acute kidney injury treatment market is bifurcated based on type, end-user, and region. In terms of type, prerenal acute kidney injury is expected to hold vast acute kidney injury treatment market share. Rise cases of low blood pressure and low blood volume remain key factors for the expansion of the market. According to industry experts at FutureWise, prerenal acute kidney injury is expected to achieve a CAGR of over 7% during the forecast period.

 

In terms of end-users, hospitals are expected to dominate the acute kidney injury treatment market growth. The financial capabilities of hospitals have allowed hospitals to purchase advanced instruments and acquire trained professionals. An increase in deployment of dialysis centres in hospitals is also escalating the acute kidney injury treatment market growth. 

 

Based on the region, North America is the global leader of the market. Factors such as the geriatric population and increasing patient population remain key reasons burgeoning the acute kidney injury treatment market in the region. The presence of developed infrastructure coupled with strong ongoing clinical procedures is fueling the market in the region. A rising number of key players and the growing preference towards advanced products are stimulating the acute kidney injury treatment market growth in countries like the U.S. and Canada.

 

Asia-Pacific is poised to be a lucrative region owing to the increasing presence of developed healthcare infrastructure and a growing patient population. Increasing geriatric population in countries like Japan and China is expected to drive the acute kidney injury treatment market growth. Rapid urbanization and rising critical care admissions are expected to positively influence the market. 

 

Prominent players of the market are AM-Pharma, Fresenius Medical Care AG & Co. KgaA., LG Chem., Asahi Kasei Medical, Angion Biomedia Corp., Baxter International, Inc., B.Braun Melsungen AG and Quark Pharmaceuticals, Inc.

 

Global Acute Kidney Injury Treatment Market Segmentation:

By Type 

● Prerenal Acute Kidney Injury 

● Intrinsic Renal Acute Kidney Injury

● Postrenal Acute Kidney Injury 

 

By End-User 

● Hospitals 

● Ambulatory Surgical Centers 

● Others 

 

By Region

North America

● Europe

● Asia Pacific

● Latin America

● Middle East & Africa

 

FutureWise Key Takeaways:

● Dialysis sector is expected to create a vast impact on the market as it's essential for critically ill patients

● Expansion of dialysis centers worldwide is expected to drive the acute kidney injury treatment market growth

● The governments of developing economies are setting up new dialysis centers, thus propelling the market

 

Objectives of the Study: 

● To provide with an exhaustive analysis on the global acute kidney injury treatment market by end-user, by type and by region

● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

● To evaluate and forecast micro-markets and the overall market 

● To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa

● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

● Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com